Switch to:
GlaxoSmithKline PLC (NYSE:GSK)
Cash And Cash Equivalents
$6,598 Mil (As of Sep. 2014)

GlaxoSmithKline PLC's quarterly cash and cash equivalents declined from Mar. 2014 ($5,886 Mil) to Jun. 2014 ($5,398 Mil) but then increased from Jun. 2014 ($5,398 Mil) to Sep. 2014 ($6,598 Mil).

GlaxoSmithKline PLC's annual cash and cash equivalents declined from Dec. 2011 ($8,873 Mil) to Dec. 2012 ($6,684 Mil) but then increased from Dec. 2012 ($6,684 Mil) to Dec. 2013 ($9,117 Mil).


Cash and cash equivalents on banks book.

Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

GlaxoSmithKline PLC Annual Data

BS_CashAndCashEquivalents 4,6357,4483,9306,6588,12610,5749,5548,8736,6849,117

GlaxoSmithKline PLC Quarterly Data

BS_CashAndCashEquivalents 11,5275,4526,6845,8684,3115,2379,1175,8865,3986,598
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial